Oklahoma Medicaid and semaglutide
Wegovy for weight loss: no. Prior authorization for heart risk reduction with established cardiovascular disease, or for noncirrhotic MASH. Ozempic for weight loss: no; for type 2 diabetes Oklahoma Medicaid must cover it. Read from Oklahoma Health Care Authority documents Nov 6, 2026.
Wegovy · Oklahoma Health Care Authority
“Wegovy ® will not be approved for obese or overweight members in the absence of established CVD”
read Nov 6, 2026
Wegovy · Oklahoma Health Care Authority
“Wegovy ® will not be approved for obese members in the absence of MASH”
read Nov 6, 2026
In 2025 Oklahoma Medicaid paid for 22,980 semaglutide prescriptions (Ozempic, Rybelsus, Wegovy), 28% of its GLP-1 prescriptions and 38th of the 50 states and DC. It reimbursed $22.4 million before rebates, $976 a prescription against $1,104 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Ozempic | 21,539 | $20.8 million | $967 |
| Rybelsus | 819 | $796,197 | $972 |
| Wegovy | 622 | $808,610 | $1,300 |
Oklahoma plans and prescribing rules
Blue Cross and Blue Shield of Oklahoma. Blue Cross and Blue Shield of Oklahoma treats GLP-1 weight-management coverage as an optional choice for employer groups. From November 1, 2026, self-funded groups with Prime Therapeutics that cover these drugs can set a $150 member cost share for up to a 30-day supply.
Semaglutide in the states around Oklahoma
| State | Sell semaglutide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Wegovy for weight loss |
|---|---|---|---|---|
| Oklahoma | 19 | $39/moWellmedr | 22,980 | Medicaid Wegovy: No |
| Arkansas | 16 | $39/moWellmedr | 4,707 | Medicaid Wegovy: No |
| Colorado | 19 | $39/moWellmedr | 26,771 | Medicaid Wegovy: No |
| Kansas | 19 | $39/moWellmedr | 13,271 | Medicaid Wegovy: Yes |
| Missouri | 18 | $39/moWellmedr | 75,811 | Medicaid Wegovy: No |
| New Mexico | 19 | $39/moWellmedr | 39,521 | Medicaid Wegovy: No |
| Texas | 19 | $39/moWellmedr | 99,830 | Medicaid Wegovy: No |



